CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–$bgne#beigene–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology companytoday announced that the Company will participate in the J.P. Morgan 41st Annual Healthcare Conferenceon Monday, January 9, 2023 at 1:30 p.m. PT.
A live webcast can be accessed from the investors section of BeiGene’s website at http://ir.beigene.com. An archived replay will be available for 90 days following the event.
About BeiGene
BeiGene is a global biotechnology company that is developing and commercializing innovative and affordable oncology medicines to improve treatment outcomes and access for far more patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 9,000 colleagues spans five continents, with administrative offices in Cambridge, U.S., & Basel, Switzerland & Beijing, China. To learn more about BeiGene, please visit www.beigene.com and follow us on Twitter at @BeiGeneGlobal.
Contacts
Investor:
Kevin Mannix
+1 240-410-0129
ir@beigene.com
Media:
Kyle Blankenship
+1 667- 351-5176
media@beigene.com
Key takeaways:Antonio Conte has officially broken his silence, dismissing speculation linking him to Manchester United…
Key takeaways:On October 23, 2026, gold rates in Chennai experienced a noticeable decline of Rs…
Key takeaways:The supplied headlines confirm India's squad reached Christchurch for a multi-format New Zealand tour,…
Key takeaways:The CA Foundation Result September 2026 is expected soon, according to NDTV, The Times…
Key takeaways:Matthew Aaron VanDyke is a U.S. national held in India in a matter Indian…
Key takeaways:India A were bowled out for 113 in the 1st Unofficial Test against New…